Challenges and Opportunities for Respiratory Syncytial Virus Vaccines

by

Write The First Customer Review

Although respiratory syncytial virus (RSV) has been a high priority for vaccine development for over 50 years now, still no vaccine is available and none has yet demonstrated sufficient promise to move to licensure. The success of RSV immune prophylaxis and the availability of ever more powerful tools to study the immune response and pathogenesis of disease, combined with the ability to construct a wide variety of vaccines using different vaccine platforms, give us grounds to believe that an RSV vaccine is within reach. ...

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines 2016, Springer

ISBN-13: 9783662521557

Softcover Reprint of the Origi edition

Trade paperback

Select
Challenges and Opportunities for Respiratory Syncytial Virus Vaccines 2013, Springer-Verlag Berlin and Heidelberg GmbH & Co. K, Berlin

ISBN-13: 9783642389184

2014 edition

Hardcover

Select